Impact of age and comorbidities on real-world outcomes in advanced breast cancer patients treated with palbociclib in first line: a nation-wide Danish retrospective study.

Acta Oncol · 2025 · PMC12175173 · PMID 40500959

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a numerical trendno p-value reported

Interestingly, the severity of comorbidities, assessed through the CCI, and the number of comorbidities did not statistically significantly impact PFS or OS, but did however show a numerical trend favoring a CCI score of 0.

also in 536 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.